https://news.medxy.ai/zh/mrd-as-a-prognostic-biomarker-in-azacitidine-and-venetoclax-treated-aml/Medxy AIzh2026-07-20T23:30:06-07:00法国 VENAURA 登记库揭示：一线阿扎胞苷联合维奈克拉治疗 AML 中，MRD 可作为强预后生物标志物 https://news.medxy.ai/ja/mrd-as-a-prognostic-biomarker-in-frontline-azacitidine-and-venetoclax-treated-aml/Medxy AIja2026-07-20T23:29:44-07:00フランスVENAURAレジストリが示す、アザシチジン＋ベネトクラクス治療AMLにおけるMRDの予後的意義 https://news.medxy.ai/vi/measurable-residual-disease-as-a-prognostic-biomarker-in-frontline-azacitidine-and-venetoclax-treated-aml/Medxy AIvi2026-07-20T23:29:19-07:00Bệnh tồn dư tối thiểu có thể đo được: dấu ấn tiên lượng nổi bật ở AML điều trị azacitidine và venetoclax hàng đầu – Góc nhìn từ cơ sở đăng ký VENAURA của Pháp https://news.medxy.ai/measurable-residual-disease-as-a-prognostic-biomarker-in-frontline-azacitidine-and-venetoclax-treated-aml-insights-from-the-french-venaura-registry/Medxy AIen2026-07-20T23:27:51-07:00Measurable Residual Disease as a Prognostic Biomarker in Frontline Azacitidine and Venetoclax-Treated AML: Insights from the French VENAURA Registry https://news.medxy.ai/zh/blinatumomab-in-high-risk-ph-negative-b-cell-all/Medxy AIzh2026-07-20T23:27:02-07:00Blinatumomab 用于高危 Ph 阴性 B-ALL 巩固治疗：GRAALL-2014/B-QUEST 研究结果 https://news.medxy.ai/ja/blinatumomab-consolidation-in-high-risk-ph-negative-b-cell-all/Medxy AIja2026-07-20T23:26:25-07:00高リスクPh陰性B細胞性急性リンパ芽球性白血病に対するブリナツモマブ地固め療法：GRAALL-2014/B-QUEST試験からの知見 https://news.medxy.ai/vi/blinatumomab-consolidation-in-high-risk-ph-negative-b-cell-acute-lymphoblastic-leukemia/Medxy AIvi2026-07-20T23:25:58-07:00Blinatumomab trong giai đoạn củng cố cho B-ALL Ph- nguy cơ cao: Những phát hiện từ nghiên cứu GRAALL-2014/B-QUEST https://news.medxy.ai/blinatumomab-consolidation-in-high-risk-ph-negative-b-cell-acute-lymphoblastic-leukemia-insights-from-the-graall-2014-b-quest-study/Medxy AIen2026-07-20T23:24:43-07:00Blinatumomab Consolidation in High-Risk Ph-Negative B-Cell Acute Lymphoblastic Leukemia: Insights from the GRAALL-2014/B-QUEST Study https://news.medxy.ai/ja/effectiveness-of-adjuvanted-rsvpref3-vaccine-in-rsv-related-hospitalization-among-us-adults-aged-%e2%89%a560-years/Medxy AIja2026-07-20T22:29:40-07:00高齢者のRSV関連入院を防ぐRSVPreF3ワクチンの実臨床有効性：米国60歳以上を対象とした包括的レビュー https://news.medxy.ai/vi/effectiveness-of-adjuvanted-rsvpref3-vaccine-in-preventing-rsv-related-hospitalization-among-us-adults-aged-%e2%89%a560-years/Medxy AIvi2026-07-20T22:29:05-07:00Hiệu quả thực tế của vắc xin RSVPreF3 có bổ trợ trong phòng ngừa nhập viện do RSV ở người lớn từ 60 tuổi trở lên tại Hoa Kỳ: Tổng quan toàn diện https://news.medxy.ai/real-world-effectiveness-of-adjuvanted-rsvpref3-vaccine-in-preventing-rsv-related-hospitalization-among-us-adults-aged-%e2%89%a560-years-a-comprehensive-review/Medxy AIen2026-07-20T22:25:57-07:00Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-Related Hospitalization Among US Adults Aged ≥60 Years: A Comprehensive Review https://news.medxy.ai/zh/mast-cells-and-endothelial-cells-in-il-33-st2-pathway-in-copd-lungs/Medxy AIzh2026-07-20T14:52:35-07:00揭示COPD肺组织中IL-33/ST2通路失调的关键细胞：肥大细胞与内皮细胞的作用 https://news.medxy.ai/ja/mast-cells-and-endothelial-cells-in-il-33-st2-pathway-dysregulation-in-copd-lungs/Medxy AIja2026-07-20T14:52:16-07:00COPD肺におけるIL-33/ST2異常の鍵を握るマスト細胞と内皮細胞の役割 https://news.medxy.ai/vi/the-roles-of-mast-cells-and-endothelial-cells-in-il-33-st2-pathway-dysregulation-in-copd-lungs/Medxy AIvi2026-07-20T14:51:55-07:00Vai trò của tế bào mast và tế bào nội mô trong rối loạn trục IL-33/ST2 ở phổi COPD https://news.medxy.ai/unveiling-the-roles-of-mast-cells-and-endothelial-cells-in-il-33-st2-pathway-dysregulation-in-copd-lungs/Medxy AIen2026-07-20T14:51:10-07:00Unveiling the Roles of Mast Cells and Endothelial Cells in IL-33/ST2 Pathway Dysregulation in COPD Lungs https://news.medxy.ai/zh/risk-of-dry-eye-disease-in-patients-with-chronic-pain-conditions/Medxy AIzh2026-07-20T14:47:56-07:00慢性疼痛患者干眼病风险升高：一项大型回顾性队列研究的新发现 https://news.medxy.ai/ja/increased-risk-of-dry-eye-disease-in-patients-with-chronic-pain-conditions/Medxy AIja2026-07-20T14:47:36-07:00慢性疼痛患者でドライアイ疾患リスクが上昇：大規模後ろ向きコホート研究から見えた知見 https://news.medxy.ai/increased-risk-of-dry-eye-disease-in-patients-with-chronic-pain-conditions-insights-from-a-large-retrospective-cohort-study/Medxy AIen2026-07-20T14:46:27-07:00Increased Risk of Dry Eye Disease in Patients with Chronic Pain Conditions: Insights from a Large Retrospective Cohort Study https://news.medxy.ai/vi/diagnostic-accuracy-of-retinal-birefringence-scanning-vs-traditional-autorefraction-in-pediatric-vision-screening/Medxy AIvi2026-07-20T14:13:42-07:00Độ chính xác chẩn đoán so sánh giữa quét lưỡng chiết võng mạc và tự khúc xạ truyền thống trong sàng lọc thị lực trẻ em https://news.medxy.ai/comparative-diagnostic-accuracy-of-retinal-birefringence-scanning-vs-traditional-autorefraction-in-pediatric-vision-screening/Medxy AIen2026-07-20T14:12:53-07:00Comparative Diagnostic Accuracy of Retinal Birefringence Scanning vs Traditional Autorefraction in Pediatric Vision Screening https://news.medxy.ai/zh/tnf-%ce%b1%e6%8a%91%e5%88%b6%e5%89%82%e4%b8%8e%e4%b8%ad%e6%9e%a2%e7%a5%9e%e7%bb%8f%e7%b3%bb%e7%bb%9f%e8%84%b1%e9%ab%93%e9%9e%98%e9%a3%8e%e9%99%a9%ef%bc%9a%e6%9d%a5%e8%87%aa%e7%be%8e%e5%9b%bd%e5%a4%a7/Medxy AIzh2026-07-20T13:45:34-07:00TNF-α抑制剂与中枢神经系统脱髓鞘风险：来自美国大型医疗网络的研究发现 https://news.medxy.ai/ja/tnf-%ce%b1%e9%98%bb%e5%ae%b3%e8%96%ac%e3%81%a8%e4%b8%ad%e6%9e%a2%e7%a5%9e%e7%b5%8c%e7%b3%bb%e8%84%b1%e9%ab%84%e3%83%aa%e3%82%b9%e3%82%af%e3%82%92%e6%a4%9c%e8%a8%bc%ef%bc%9a%e7%b1%b3%e5%9b%bd%e5%a4%a7/Medxy AIja2026-07-20T13:45:16-07:00TNF-α阻害薬と中枢神経系脱髄リスクを検証：米国大規模医療ネットワークからの知見 https://news.medxy.ai/vi/danh-gia-nguy-co-mat-myelin-he-than-kinh-trung-uong-lien-quan-den-chat-uc-che-tnf-%ce%b1-goc-nhin-tu-mot-mang-luoi-y-te-quy-mo-lon-tai-hoa-ky/Medxy AIvi2026-07-20T13:44:56-07:00Đánh giá nguy cơ mất myelin hệ thần kinh trung ương liên quan đến chất ức chế TNF-α: Góc nhìn từ một mạng lưới y tế quy mô lớn tại Hoa Kỳ https://news.medxy.ai/assessing-the-risk-of-cns-demyelination-associated-with-tnf-%ce%b1-inhibitors-insights-from-a-large-us-health-network/Medxy AIen2026-07-20T13:44:08-07:00Assessing the Risk of CNS Demyelination Associated with TNF-α Inhibitors: Insights from a Large US Health Network https://news.medxy.ai/ja/%e9%bc%bb%e5%89%af%e9%bc%bb%e8%85%94%e8%85%ab%e7%98%a4%e3%82%92%e3%81%a9%e3%81%86%e8%a9%95%e4%be%a1%e3%81%99%e3%82%8b%e3%81%8b%ef%bc%9a%e5%ad%a6%e9%9a%9b%e7%9a%84%e3%82%b3%e3%83%b3%e3%82%bb%e3%83%b3/Medxy AIja2026-07-20T11:59:11-07:00鼻副鼻腔腫瘤をどう評価するか：学際的コンセンサスが示す重要ポイント https://news.medxy.ai/vi/danh-gia-khoi-vung-mui-xoang-nhu-the-nao-nhung-khuyen-nghi-trong-tam-tu-dong-thuan-da-chuyen-nganh/Medxy AIvi2026-07-20T11:58:38-07:00Đánh giá khối vùng mũi-xoang như thế nào: Những khuyến nghị trọng tâm từ đồng thuận đa chuyên ngành https://news.medxy.ai/zh/%e5%a6%82%e4%bd%95%e8%af%84%e4%bc%b0%e9%bc%bb%e7%aa%a6%e9%bc%bb%e8%85%94%e5%8d%a0%e4%bd%8d%ef%bc%9a%e5%a4%9a%e5%ad%a6%e7%a7%91%e5%85%b1%e8%af%86%e7%9a%84%e5%85%b3%e9%94%ae%e5%bb%ba%e8%ae%ae/Medxy AIzh2026-07-20T11:58:07-07:00如何评估鼻窦鼻腔占位：多学科共识的关键建议 https://news.medxy.ai/how-to-evaluate-a-sinonasal-mass-key-recommendations-from-a-multidisciplinary-consensus/Medxy AIen2026-07-20T11:56:41-07:00How to Evaluate a Sinonasal Mass: Key Recommendations from a Multidisciplinary Consensus https://news.medxy.ai/zh/outcomes-of-endoscopic-choanal-atresia-repair/Medxy AIzh2026-07-20T11:54:54-07:00无支架内镜修复先天性后鼻孔闭锁的长期结局：一项10年儿科队列研究 https://news.medxy.ai/ja/outcomes-of-endoscopic-choanal-atresia-repair-using-mucoperiosteal-flaps/Medxy AIja2026-07-20T11:54:36-07:00ステント非留置のムコペリオステアル弁による後鼻孔閉鎖内視鏡修復の長期成績：小児10年コホートからの知見 https://news.medxy.ai/vi/long-term-outcomes-of-endoscopic-choanal-atresia-repair-using-mucoperiosteal-flaps-without-stenting/Medxy AIvi2026-07-20T11:54:13-07:00Kết quả dài hạn của sửa chữa nội soi tịt cửa mũi sau bằng vạt niêm mạc–màng xương không đặt stent: kinh nghiệm 10 năm ở trẻ em https://news.medxy.ai/long-term-outcomes-of-endoscopic-choanal-atresia-repair-using-mucoperiosteal-flaps-without-stenting-insights-from-a-10-year-pediatric-cohort/Medxy AIen2026-07-20T11:53:27-07:00Long-Term Outcomes of Endoscopic Choanal Atresia Repair Using Mucoperiosteal Flaps Without Stenting: Insights from a 10-Year Pediatric Cohort https://news.medxy.ai/zh/quality-of-life-in-malignant-bowel-obstruction/Medxy AIzh2026-07-20T11:46:57-07:00减压性胃造口管在恶性肠梗阻中的生活质量获益：一项回顾性队列研究 https://news.medxy.ai/ja/quality-of-life-with-venting-gastrostomy-tubes-in-malignant-bowel-obstruction/Medxy AIja2026-07-20T11:46:42-07:00悪性腸閉塞に対する venting gastrostomy tube で生活の質を改善する：後ろ向きコホート研究からの示唆 https://news.medxy.ai/vi/improving-quality-of-life-with-venting-gastrostomy-tubes-in-malignant-bowel-obstruction/Medxy AIvi2026-07-20T11:46:26-07:00Nâng cao chất lượng sống bằng ống mở thông dạ dày dẫn lưu trong tắc ruột do ung thư: phát hiện từ một nghiên cứu đoàn hệ hồi cứu https://news.medxy.ai/improving-quality-of-life-with-venting-gastrostomy-tubes-in-malignant-bowel-obstruction-insights-from-a-retrospective-cohort-study/Medxy AIen2026-07-20T11:45:52-07:00Improving Quality of Life with Venting Gastrostomy Tubes in Malignant Bowel Obstruction: Insights from a Retrospective Cohort Study https://news.medxy.ai/zh/toripalimab-enhances-surgical-outcomes-and-survival-in-stage-iii-resectable-nsclc/Medxy AIzh2026-07-20T11:36:05-07:00围手术期特瑞普利单抗联合化疗可显著提高Ⅲ期可切除非小细胞肺癌手术率及生存 https://news.medxy.ai/ja/perioperative-toripalimab-enhances-surgical-outcomes-and-survival-in-stage-iii-resectable-nsclc-2/Medxy AIja2026-07-20T11:35:46-07:00切除可能III期NSCLCに対する周術期トリパリマブが手術成績と生存を改善：Neotorch試験の知見 https://news.medxy.ai/vi/perioperative-toripalimab-enhances-surgical-outcomes-and-survival-in-stage-iii-resectable-nsclc/Medxy AIvi2026-07-20T11:35:24-07:00Toripalimab chu phẫu giúp cải thiện kết quả phẫu thuật và sống còn ở NSCLC giai đoạn III có thể cắt bỏ: Góc nhìn từ nghiên cứu Neotorch https://news.medxy.ai/perioperative-toripalimab-enhances-surgical-outcomes-and-survival-in-stage-iii-resectable-nsclc-insights-from-the-neotorch-trial/Medxy AIen2026-07-20T11:34:32-07:00Perioperative Toripalimab Enhances Surgical Outcomes and Survival in Stage III Resectable NSCLC: Insights from the Neotorch Trial https://news.medxy.ai/health-insurance-instability-following-firearm-injury-a-matched-cohort-case-report/Medxy AIen2026-07-20T11:30:08-07:00Health Insurance Instability Following Firearm Injury: A Matched Cohort Case Report https://news.medxy.ai/unraveling-failure-to-rescue-in-major-gynecologic-cancer-surgery-insights-from-a-nsqip-analysis/Medxy AIen2026-07-20T11:27:54-07:00Unraveling Failure to Rescue in Major Gynecologic Cancer Surgery: Insights from a NSQIP Analysis https://news.medxy.ai/zh/decoding-placental-pathology-risks-in-dichorionic-twins-in-ultrasound-phenotypes/Medxy AIzh2026-07-20T11:17:50-07:00双绒毛膜双胎胎盘病理风险如何分层？超声表型揭示胎儿生长受损的不同风险 https://news.medxy.ai/ja/placental-pathology-risks-in-dichorionic-twins/Medxy AIja2026-07-20T11:17:29-07:00二絨毛膜双胎の胎盤病理リスクを読み解く：胎児発育障害の超音波表現型 https://news.medxy.ai/vi/placental-pathology-risks-in-dichorionic-twins-of-fetal-growth-impairment/Medxy AIvi2026-07-20T11:16:58-07:00Giải mã nguy cơ bệnh lý nhau thai ở song thai hai bánh nhau: Các kiểu hình siêu âm của suy giảm tăng trưởng thai https://news.medxy.ai/decoding-placental-pathology-risks-in-dichorionic-twins-ultrasound-phenotypes-of-fetal-growth-impairment/Medxy AIen2026-07-20T11:16:09-07:00Decoding Placental Pathology Risks in Dichorionic Twins: Ultrasound Phenotypes of Fetal Growth Impairment https://news.medxy.ai/zh/long-term-benefits-of-hormone-therapy-in-young-cervical-cancer/Medxy AIzh2026-07-20T11:02:54-07:00年轻宫颈癌幸存者接受放化疗后激素治疗的安全性及长期获益 https://news.medxy.ai/ja/long-term-benefits-of-hormone-therapy-after-chemoradiation-in-young-cervical-cancer/Medxy AIja2026-07-20T11:02:35-07:00化学放射線療法後のホルモン療法：若年子宮頸癌サバイバーにおける安全性と長期利益 https://news.medxy.ai/vi/safety-and-long-term-benefits-of-hormone-therapy-after-chemoradiation-in-young-cervical-cancer/Medxy AIvi2026-07-20T11:02:12-07:00Liệu pháp hormone sau hóa xạ trị: an toàn và lợi ích dài hạn ở người sống sót trẻ sau ung thư cổ tử cung https://news.medxy.ai/safety-and-long-term-benefits-of-hormone-therapy-after-chemoradiation-in-young-cervical-cancer-survivors/Medxy AIen2026-07-20T11:01:17-07:00Safety and Long-Term Benefits of Hormone Therapy After Chemoradiation in Young Cervical Cancer Survivors https://news.medxy.ai/ja/neurodevelopmental-outcomes-in-late-preterm-hypoglycemia/Medxy AIja2026-07-20T10:59:51-07:00後期早産児の低血糖後にみられる神経発達転帰 https://news.medxy.ai/vi/child-neurodevelopmental-outcomes-in-late-preterm-hypoglycemia/Medxy AIvi2026-07-20T10:59:31-07:00Hạ đường huyết ở trẻ sinh non muộn và kết cục phát triển thần kinh: phát hiện đáng yên tâm https://news.medxy.ai/child-neurodevelopmental-outcomes-after-late-preterm-hypoglycemia/Medxy AIen2026-07-20T10:58:40-07:00Child Neurodevelopmental Outcomes After Late Preterm Hypoglycemia https://news.medxy.ai/ja/decompensated-cirrhosis-in-metabolic-dysfunction-related-steatotic-liver-disease/Medxy AIja2026-07-20T10:55:07-07:00MASLD・MetALD関連非代償性肝硬変を再代償化へ導くには：禁酒、減量、心代謝管理の重要性 https://news.medxy.ai/vi/decompensated-cirrhosis-in-mdsld/Medxy AIvi2026-07-20T10:54:44-07:00Tái bù xơ gan mất bù trong bệnh gan nhiễm mỡ liên quan rối loạn chuyển hóa: Vai trò của kiêng rượu, giảm cân và kiểm soát tim chuyển hóa https://news.medxy.ai/zh/il-17-ngal-nets-itga5-axis-overcome-in-pancreatic-cancer/Medxy AIzh2026-07-20T10:14:33-07:00靶向IL-17/NGAL/NETs/ITGA5轴：克服胰腺癌免疫抑制与成纤维细胞重编程的新策略 https://news.medxy.ai/vi/targeting-the-il-17-ngal-nets-itga5-axis-in-pancreatic-cancer/Medxy AIvi2026-07-20T10:13:47-07:00Nhắm trúng trục IL-17/NGAL/NETs/ITGA5: Chiến lược mới để vượt qua ức chế miễn dịch và tái lập trình nguyên bào sợi trong ung thư tụy https://news.medxy.ai/targeting-the-il-17-ngal-nets-itga5-axis-a-novel-strategy-to-overcome-immunosuppression-and-fibroblast-reprogramming-in-pancreatic-cancer/Medxy AIen2026-07-20T10:12:13-07:00Targeting the IL-17/NGAL/NETs/ITGA5 Axis: A Novel Strategy to Overcome Immunosuppression and Fibroblast Reprogramming in Pancreatic Cancer https://news.medxy.ai/dr5-ligase-3-feedback-loop-unlocking-the-immunogenicity-of-mismatch-repair-deficient-colorectal-cancer/Medxy AIen2026-07-20T10:08:18-07:00DR5/Ligase 3 Feedback Loop: Unlocking the Immunogenicity of Mismatch Repair-Deficient Colorectal Cancer https://news.medxy.ai/zh/brain-perivascular-space-morphometry-on-microvascular-traits-and-neuropsychiatric-factors/Medxy AIzh2026-07-20T08:49:01-07:00脑周血管间隙形态计量学揭示家族性微血管特征与神经精神影响 https://news.medxy.ai/ja/microvascular-traits-and-neuropsychiatric-factors-in-brain-perivascular-space-morphometry/Medxy AIja2026-07-20T08:48:40-07:00脳周囲血管腔の形態から見えた家族性微小血管特性と神経精神医学的因子 https://news.medxy.ai/vi/familial-microvascular-traits-and-neuropsychiatric-factors-in-brain-perivascular-space-morphometry/Medxy AIvi2026-07-20T08:48:18-07:00Đặc điểm vi mạch gia đình và yếu tố tâm thần kinh qua hình thái các khoang quanh mạch máu não https://news.medxy.ai/familial-microvascular-traits-and-neuropsychiatric-factors-reflected-in-brain-perivascular-space-morphometry/Medxy AIen2026-07-20T08:46:35-07:00Familial Microvascular Traits and Neuropsychiatric Factors Reflected in Brain Perivascular Space Morphometry https://news.medxy.ai/zh/effectiveness-and-safety-of-emerging-myasthenia-gravis-therapies/Medxy AIzh2026-07-20T08:36:01-07:00新兴重症肌无力治疗的疗效与安全性比较：来自 Bayesian 网络荟萃分析的启示 https://news.medxy.ai/vi/comparative-effectiveness-and-safety-of-emerging-myasthenia-gravis-therapies/Medxy AIvi2026-07-20T08:35:06-07:00Hiệu quả và độ an toàn so sánh của các liệu pháp mới trong nhược cơ: Góc nhìn từ phân tích tổng hợp mạng Bayesian https://news.medxy.ai/comparative-effectiveness-and-safety-of-emerging-myasthenia-gravis-therapies-insights-from-a-bayesian-network-meta-analysis/Medxy AIen2026-07-20T08:33:39-07:00Comparative Effectiveness and Safety of Emerging Myasthenia Gravis Therapies: Insights From a Bayesian Network Meta-Analysis https://news.medxy.ai/ja/participant-reported-outcomes-residual-beta-cell-function-in-youth-with-newly-diagnosed-t1dm/Medxy AIja2026-07-20T08:32:42-07:00新規診断1型糖尿病の若年者における患者報告アウトカム、残存β細胞機能、代謝指標の関連 https://news.medxy.ai/vi/participant-reported-outcomes-residual-beta-cell-function-and-metabolic-parameters-in-youth-with-newly-diagnosed-t1dm/Medxy AIvi2026-07-20T08:32:21-07:00Mối liên quan giữa kết cục do người tham gia báo cáo, chức năng tế bào beta còn lại và các chỉ số chuyển hóa ở trẻ em và thanh thiếu niên mới được chẩn đoán đái tháo đường type 1 https://news.medxy.ai/relationship-between-participant-reported-outcomes-residual-beta-cell-function-and-metabolic-parameters-in-youth-with-newly-diagnosed-type-1-diabetes/Medxy AIen2026-07-20T08:31:10-07:00Relationship between Participant-Reported Outcomes, Residual Beta Cell Function, and Metabolic Parameters in Youth with Newly Diagnosed Type 1 Diabetes https://news.medxy.ai/zh/anti-zscan1-antibodies-in-diagnosis-and-management-for-rohhad-net-syndrome/Medxy AIzh2026-07-19T10:28:30-07:00解读ROHHAD-NET综合征：临床要点及抗ZSCAN1抗体在诊断与管理中的作用 https://news.medxy.ai/ja/rohhad-net-syndrome-and-anti-zscan1-antibodies/Medxy AIja2026-07-19T10:28:13-07:00ROHHAD-NET症候群を読み解く：臨床的示唆と診断・管理におけるanti-ZSCAN1抗体の役割 https://news.medxy.ai/vi/rohhad-net-syndrome-and-anti-zscan1-antibodies-in-diagnosis-and-management/Medxy AIvi2026-07-19T10:27:54-07:00Giải mã hội chứng ROHHAD-NET: Thông tin lâm sàng và vai trò của kháng thể anti-ZSCAN1 trong chẩn đoán và xử trí https://news.medxy.ai/unraveling-rohhad-net-syndrome-clinical-insights-and-the-role-of-anti-zscan1-antibodies-in-diagnosis-and-management/Medxy AIen2026-07-19T10:27:13-07:00Unraveling ROHHAD-NET Syndrome: Clinical Insights and the Role of Anti-ZSCAN1 Antibodies in Diagnosis and Management https://news.medxy.ai/zh/igg-n-glycosylation-for-diabetic-nephropathy-in-type-2-diabetes/Medxy AIzh2026-07-19T09:05:26-07:00IgG N-糖基化特征：2型糖尿病患者糖尿病肾病的潜在预测生物标志物——基于汇总前瞻性队列分析的研究洞见 https://news.medxy.ai/ja/igg-n-glycosylation-profiles-for-diabetic-nephropathy-in-type-2-diabetes/Medxy AIja2026-07-19T09:05:00-07:002型糖尿病における糖尿病性腎症の予測バイオマーカーとしての IgG N-グリコシル化プロファイル：統合前向きコホート解析からの知見 https://news.medxy.ai/vi/igg-n-glycosylation-profiles-as-predictive-biomarkers-for-diabetic-nephropathy-in-type-2-diabetes/Medxy AIvi2026-07-19T09:04:42-07:00Hồ sơ N-glycosyl hóa IgG có thể dự báo bệnh thận do đái tháo đường ở đái tháo đường type 2: phát hiện từ phân tích gộp tiền cứu đa đoàn hệ https://news.medxy.ai/igg-n-glycosylation-profiles-as-predictive-biomarkers-for-diabetic-nephropathy-in-type-2-diabetes-insights-from-a-pooled-prospective-cohort-analysis/Medxy AIen2026-07-19T09:03:18-07:00IgG N-Glycosylation Profiles as Predictive Biomarkers for Diabetic Nephropathy in Type 2 Diabetes: Insights from a Pooled Prospective Cohort Analysis